Literature DB >> 19457373

Cerebral morphology and dopamine D2/D3 receptor distribution in humans: a combined [18F]fallypride and voxel-based morphometry study.

Neil D Woodward1, David H Zald, Zhaohua Ding, Patrizia Riccardi, M Sib Ansari, Ronald M Baldwin, Ronald L Cowan, Rui Li, Robert M Kessler.   

Abstract

The relationship between cerebral morphology and the expression of dopamine receptors has not been extensively studied in humans. Elucidation of such relationships may have important methodological implications for clinical studies of dopamine receptor ligand binding differences between control and patient groups. The association between cerebral morphology and dopamine receptor distribution was examined in 45 healthy subjects who completed T1-weighted structural MRI and PET scanning with the D(2)/D(3) ligand [(18)F]fallypride. Optimized voxel-based morphometry was used to create grey matter volume and density images. Grey matter volume and density images were correlated with binding potential (BP(ND)) images on a voxel-by-voxel basis using the Biological Parametric Mapping toolbox. Associations between cerebral morphology and BP(ND) were also examined for selected regions-of-interest (ROIs) after spatial normalization. Voxel-wise analyses indicated that grey matter volume and density positively correlated with BP(ND) throughout the midbrain, including the substantia nigra. Positive correlations were observed in medial cortical areas, including anterior cingulate and medial prefrontal cortex, and circumscribed regions of the temporal, frontal, and parietal lobes. ROI analyses revealed significant positive correlations between BP(ND) and cerebral morphology in the caudate, thalamus, and amygdala. Few negative correlations between morphology and BP(ND) were observed. Overall, grey matter density appeared more strongly correlated with BP(ND) than grey matter volume. Cerebral morphology, particularly grey matter density, correlates with [(18)F]fallypride BP(ND) in a regionally specific manner. Clinical studies comparing dopamine receptor availability between clinical and control groups may benefit by accounting for potential differences in cerebral morphology that exist even after spatial normalization.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19457373      PMCID: PMC2804466          DOI: 10.1016/j.neuroimage.2009.01.049

Source DB:  PubMed          Journal:  Neuroimage        ISSN: 1053-8119            Impact factor:   6.556


  44 in total

1.  D2 but not D3 receptors are elevated after 9 or 11 months chronic haloperidol treatment: influence of withdrawal period.

Authors:  J N Joyce
Journal:  Synapse       Date:  2001-05       Impact factor: 2.562

Review 2.  Voxel-based morphometry--the methods.

Authors:  J Ashburner; K J Friston
Journal:  Neuroimage       Date:  2000-06       Impact factor: 6.556

3.  Image registration by maximization of combined mutual information and gradient information.

Authors:  J P Pluim; J B Maintz; M A Viergever
Journal:  IEEE Trans Med Imaging       Date:  2000-08       Impact factor: 10.048

4.  Brain imaging of 18F-fallypride in normal volunteers: blood analysis, distribution, test-retest studies, and preliminary assessment of sensitivity to aging effects on dopamine D-2/D-3 receptors.

Authors:  Jogeshwar Mukherjee; Bradley T Christian; Kelly A Dunigan; Bingzhi Shi; Tanjore K Narayanan; Martin Satter; Joseph Mantil
Journal:  Synapse       Date:  2002-12-01       Impact factor: 2.562

5.  The relation between dopamine D2 receptor density and personality: preliminary evidence from the NEO personality inventory-revised.

Authors:  L P Kestler; A K Malhotra; C Finch; C Adler; A Breier
Journal:  Neuropsychiatry Neuropsychol Behav Neurol       Date:  2000-01

6.  Effects of genetic depletion of monoamines on somatosensory cortical development.

Authors:  C Alvarez; T Vitalis; E A Fon; N Hanoun; M Hamon; I Seif; R Edwards; P Gaspar; O Cases
Journal:  Neuroscience       Date:  2002       Impact factor: 3.590

7.  A voxel-based morphometric study of ageing in 465 normal adult human brains.

Authors:  C D Good; I S Johnsrude; J Ashburner; R N Henson; K J Friston; R S Frackowiak
Journal:  Neuroimage       Date:  2001-07       Impact factor: 6.556

8.  Navigation-related structural change in the hippocampi of taxi drivers.

Authors:  E A Maguire; D G Gadian; I S Johnsrude; C D Good; J Ashburner; R S Frackowiak; C D Frith
Journal:  Proc Natl Acad Sci U S A       Date:  2000-04-11       Impact factor: 11.205

Review 9.  A review of MRI findings in schizophrenia.

Authors:  M E Shenton; C C Dickey; M Frumin; R W McCarley
Journal:  Schizophr Res       Date:  2001-04-15       Impact factor: 4.939

Review 10.  Imaging dopamine's role in drug abuse and addiction.

Authors:  N D Volkow; J S Fowler; G J Wang; R Baler; F Telang
Journal:  Neuropharmacology       Date:  2008-06-03       Impact factor: 5.250

View more
  34 in total

1.  PET evidence for a role for striatal dopamine in the attentional blink: functional implications.

Authors:  Heleen A Slagter; Rachel Tomer; Bradley T Christian; Andrew S Fox; Lorenza S Colzato; Carlye R King; Dhanabalan Murali; Richard J Davidson
Journal:  J Cogn Neurosci       Date:  2012-06-04       Impact factor: 3.225

2.  Evidence for chronically altered serotonin function in the cerebral cortex of female 3,4-methylenedioxymethamphetamine polydrug users.

Authors:  Christina R Di Iorio; Tristan J Watkins; Mary S Dietrich; Aize Cao; Jennifer U Blackford; Baxter Rogers; Mohammed S Ansari; Ronald M Baldwin; Rui Li; Robert M Kessler; Ronald M Salomon; Margaret Benningfield; Ronald L Cowan
Journal:  Arch Gen Psychiatry       Date:  2011-12-05

Review 3.  Neuroimaging in psychiatric disorders.

Authors:  Joseph C Masdeu
Journal:  Neurotherapeutics       Date:  2011-01       Impact factor: 7.620

4.  Subcortical intelligence: caudate volume predicts IQ in healthy adults.

Authors:  Rachael G Grazioplene; Sephira G Ryman; Jeremy R Gray; Aldo Rustichini; Rex E Jung; Colin G DeYoung
Journal:  Hum Brain Mapp       Date:  2014-12-09       Impact factor: 5.038

5.  Neurocognitive profile of patients with X-linked dystonia-parkinsonism.

Authors:  Roland Dominic G Jamora; Cezar Thomas R Suratos; Jesi Ellen C Bautista; Gail Melissa I Ramiro; Ana Westenberger; Christine Klein; Lourdes K Ledesma
Journal:  J Neural Transm (Vienna)       Date:  2021-02-27       Impact factor: 3.575

6.  Orbitofrontal and caudate volumes in cannabis users: a multi-site mega-analysis comparing dependent versus non-dependent users.

Authors:  Yann Chye; Nadia Solowij; Chao Suo; Albert Batalla; Janna Cousijn; Anna E Goudriaan; Rocio Martin-Santos; Sarah Whittle; Valentina Lorenzetti; Murat Yücel
Journal:  Psychopharmacology (Berl)       Date:  2017-04-01       Impact factor: 4.530

Review 7.  Pain, affective symptoms, and cognitive deficits in patients with cerebral dopamine dysfunction.

Authors:  Johanna M Jarcho; Emeran A Mayer; Ziyue Karen Jiang; Natasha A Feier; Edythe D London
Journal:  Pain       Date:  2012-03-03       Impact factor: 6.961

8.  Striatal morphology is associated with tobacco cigarette craving.

Authors:  Amy C Janes; Min Tae M Park; Stacey Farmer; M Mallar Chakravarty
Journal:  Neuropsychopharmacology       Date:  2014-07-24       Impact factor: 7.853

9.  Caudate asymmetry is related to attentional impulsivity and an objective measure of ADHD-like attentional problems in healthy adults.

Authors:  Linh C Dang; Gregory R Samanez-Larkin; Jacob S Young; Ronald L Cowan; Robert M Kessler; David H Zald
Journal:  Brain Struct Funct       Date:  2014-10-01       Impact factor: 3.270

10.  The relationship between subcortical brain volume and striatal dopamine D2/3 receptor availability in healthy humans assessed with [11 C]-raclopride and [11 C]-(+)-PHNO PET.

Authors:  Fernando Caravaggio; Jun Ku Chung; Eric Plitman; Isabelle Boileau; Philip Gerretsen; Julia Kim; Yusuke Iwata; Raihaan Patel; M Mallar Chakravarty; Gary Remington; Ariel Graff-Guerrero
Journal:  Hum Brain Mapp       Date:  2017-07-28       Impact factor: 5.038

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.